Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84688fcbbe900b3fc438d73ac17738f5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
filingDate |
1999-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_716d71fd62bae949c1af4191180a208c |
publicationDate |
1999-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0960619-A1 |
titleOfInvention |
Sustained release analgesic compositions comprising tilidine |
abstract |
The invention relates to solid retardants which can be applied orallynPainkillers containing tilidine.n n n These contain tilidine as the salt of a complexing agent for 2- or 3-valentnMetal cations or usual tilidine salts in combination with a complexing agentnfor 2- or 3-valent metal cations and a morphine antagonist, the in-vitronRelease rate of tilidine and morphine antagonist essentiallynare the same. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1685828-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115252583-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016091805-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115252583-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1382338-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115120568-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115120568-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2425824-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2425821-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1374859-A1 |
priorityDate |
1998-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |